Sentences with phrase «development stage technology company»

Energous Corp is a development stage technology company.

Energous Corp. is a development stage technology company, which develops technology that can enable wireless charging or powering of electronic devices at distance.

Not exact matches

For a smaller company like Bioastra, OI is a direct and relatively risk - free path to monetizing technology in the very early stages of product development.

[1] It remains early in the development of businesses around the technology, with many startups still in the proof - of - concept stage — however, if successful, these companies are poised to generate tremendous value.

The company's lead candidate is Trevyent, a development stage drug product that utilizes SteadyMed's PatchPump technology to administer treprostinil, a vasodilatory prostacyclin analogue to treat pulmonary arterial hypertension.

BDC Venture Capital is a major venture capital investor in Canada, active at every stage of the company's development cycle, from seed through expansion, with a focus on innovative technology - based Canadian companies that have high growth potential, offer unique products or services and that are positioned to become dominant players in their markets.

He has been actively involved in technology commercialisation at every stage of the process including implementation of technology development and intellectual property (IP) strategies, capital raisings and has performed executive management roles in early stage companies.

Coinsilium is an accelerator that finances and manages the development of early - stage blockchain technology companies.

About Alberta Enterprise: Alberta Enterprise promotes the development of Alberta's venture capital industry by investing in VC funds that finance early stage technology companies.

About Alberta Enterprise Corporation: Alberta Enterprise Corporation promotes the development of Alberta's venture capital industry by investing in venture capital funds that finance early - stage technology companies.

I represent technology and growth companies at all stages of development, through private financings, strategic transactions, public offerings, and mergers and acquisitions.

♦ Lead Business Analyst & Technical Architect for Adobe Campaign, Adobe Analytics & Adobe Target Implementations for Fortune 1,000 companies ♦ Key strategic member of sales and business development teams by providing expert solutions to prospects leading to purchasing digital marketing technologies and services ♦ Lead expert technical consultant teams in delivering enterprise and mid-market project implementations and configurations ♦ Guide solutions consultants on digital marketing mental agility to discover upselling & cross-selling opportunities ♦ Collaborate with solutions consultant team in charge of rendering sales support and resolving prospect inquiries during all stages of the sales cycle contributing to 3.5 MM in new business sales.

Pieter is a seasoned advisor, investor, and mentor is President & CEO of Redpeaks Management Inc., a consulting firm focused on advising early - stage technology companies on finance and investment, corporate development, legal structure, and overall business strategies.

The Summit will also feature a «Startup Showcase» curated by InSITE Fellows (a prominent technology leadership development program), where early stage entrepreneurs will be given a platform to present their companies to TechTable attendees.

This is generally the point where the company has preliminary proof - of - concept of a technology and needs that $ 1 million to $ 3 million to get to the next stage of development.

RRAM technology (sometimes called ReRAM) is in a relatively early stage of development but has managed to garner attention from HP, Sharp, Samsung and several other companies that have received RRAM - related patents in the past decade.

PNP Therapeutics ®, Inc., is an early - stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer.

Table 1: Selection, Design & Construction of HSV - based Oncolytic Viruses Table 2: Selection, Design & Construction of Adenovirus - based Oncolytic Viruses Table 3: Selection, Design & Construction of Vaccinia Virus - based Oncolytic Viruses Table 4: Selection, Design & Construction of Vesicular Stomatitis Virus - based Oncolytic Viruses Table 5: Selection, Design & Construction of Newcastle Disease Virus - based Oncolytic Viruses Table 6: Selection, Design & Construction of Various Virus - based Oncolytic Viruses Table 7: Current Company - Sponsored Clinical Trials of T - Vec Table 8: Clinical Trials of ColoAd1 Table 9: Clinical Trials with JX - 594 Table 10: Clinical Trials with GL - ONC1 Table 11: Clinical Trials of CAVATAK (CVA21) Table 12: Clinical Trials with MV - NIS Table 13: Overview of Oncolytic Viruses by Development Phase & Virus Family Table 14: Profile of Approved and Marketed Oncolytic Viruses Table 15: Pivotal Study Design of Oncolytic Viruses in Late Stage Development Based on Previous Clinical Results Table 16: Approved Indications of Immune Checkpoint Inhibitors Table 17: Active Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 18: Planned Clinical Studies of Oncolytic Viruses in Combination with Immune Checkpoint Inhibitors (ICI) Table 19: Active or Planned Clinical Studies of Oncolytic Viruses in Combination with Other Anti-Cancer Therapeutics Table 20: Pattern of Transgenes in Oncolytic Viruses in Relation to Development Phase Tables 21a and 21b: Indications and Frquency and Way of Administration of Oncolytic Viruses in Active and / or Positive Completed Clinical Studies Table 22: Small and Medium Pharma & Biotech as Partner for Regional Co-Development of Oncolytic Viruses Table 23: Immuno - Oncology Portfolio of Major Pharma & Biotech with Interest in Oncolytic Viruses Table 24: Interests of Major Pharma & Biotech in Oncolytic Viruses Table 25: First Generation Oncology Virus Companies and their Sources of Technology Table 26: Second Generation Oncology Virus Companies and their Sources of Technology Table 27: Third Generation Oncology Virus Companies and their Sources of Technology Table 28: Fourth Generation Oncology Virus Companies and their Sources of Technology Table 29: Grants, Credits & Donations Table 30: Financing by Venture Capital, Private Equity and Other Private Placements Table 31: Collaboration & Licensing Agreements Table 32: Companies Listed on Stock Exchange & Offerings Table 33: Mergers & Acquisitions

In fact, when a penny stock shoots up on the news of big - company involvement, and the mineral property / unproven technology / revolutionary software is still in the early stages of development, it's often a good time to sell.

Nektar Therapeutics, Inc. is clinical - stage biopharmaceutical Company, which is engaged in the development of drug candidates that utilize its PEGylation & advanced polymer conjugate technology platforms.

We provide a comprehensive array of technology legal services for companies in all stages of development, from conception through profitability and beyond.

For life sciences companies in every stage of development, the emerging business and technology team at Morgan Lewis provides customized legal guidance and international connection to address critical business issues.Our lawyers and technical specialists in North America, Asia, Europe, and the Middle East deliver pragmatic, goal - oriented advice for life sciences companies.

Coinsilium Group Limited (NEX: COIN), a London - based blockchain technology - focused investment and development company, supporting early - stage blockchain companies through investment, acceleration, development and education, is pleased to announce that it has successfully raised # 187,985 gross of expenses through the issue of 18,798,500 ordinary shares of no par value («Ordinary Shares») at a price of 1 pence per share (the «Subscription»), mainly supported by existing shareholders and all current directors.

Further to the announcement of back in January 2018, Coinsilium Group, the blockchain venture builder, investor, and advisor that finances and manages the development of early - stage blockchain technology companies today announced that it has exercised its option to acquire a further 3.5 % of the share capital of Indorse.

Coinsilium is a blockchain venture builder and investor that finances and manages the development of early - stage blockchain technology companies.

London, UK, 6 February 2018 — Coinsilium Group Limited (NEX: COIN), the blockchain venture builder and investor that finances and manages the development of early - stage blockchain technology companies, is pleased to announce that its Advisory Services» client, Dether Limited («Dether»), the peer - to - peer ecosystem of crypto buyers, sellers and physical shops, will begin its token generating event («TGE») on 7 February at 2 pm CET.

«At this point, Apple is the only company who is able to roll out micro-LED, a technology that is still at an early stage of development, and cover the high costs incurred by the low yield rate,» said a source that spoke to Nikkei.

Coinsilium, the blockchain venture builder and investor that finances and manages the development of early - stage blockchain technology companies, is pleased to announce its unaudited consolidated interim financial statements for the six months ended 30 June 2017.

Coinsilium Group Limited (NEX: COIN), the blockchain venture builder and investor that finances and manages the development of early - stage blockchain technology companies, is pleased to announce it has acquired a 30 % equity stake in StartupToken Limited («StartupToken»), a provider of

Mashable interviewed six experts in the field at various stages in their careers to get their tips on what it takes to become a business development professional at technology companies and startups.

Conn has more than 20 years of experience, including as principal at Moderne Ventures, an early - stage venture fund and accelerator program for real estate technology companies; vice president of Corporate Development for Move, Inc., where she led acquisitions including of FiveStreet, ListHub and TigerLead; and with the Tribune Company, where she was involved with the conception and execution of strategic initiatives, including acquisitions and joint ventures with Apartments.com and HomeFinder.com.